Depression Treatment – Safe & Effective | Kunal Patra, MD

The practice follows the guidelines developed. from the NIHM clinical trial protocol calling for six intravenous infusions over a two-week period. The duration of benefit varies from one individual to another though subsequent treatment sessions may be needed. That is a determination that is jointly made by the patient. and the treating psychiatrist. One needs to keep in mind that there is no guarantee that every individual. who tries this treatment will experience similar benefit as individual results vary. With a close to 70% response rate in the literature, Ketamine is being hailed as an unprecedentedly successful. advance in the treatment of treatment-resistant depression, PTSD and chronic pain. hfarazm
The practice follows the guidelines developed. from the NIHM clinical trial protocol calling for six intravenous infusions over a two-week period. The duration of benefit varies from one individual to another though subsequent treatment sessions may be needed. That is a determination that is jointly made by the patient. and the treating psychiatrist. One needs to keep in mind that there is no guarantee that every individual. who tries this treatment will experience similar benefit as individual results vary. With a close to 70% response rate in the literature, Ketamine is being hailed as an unprecedentedly successful. advance in the treatment of treatment-resistant depression, PTSD and chronic pain.The practice follows the guidelines developed. from the NIHM clinical trial protocol calling for six intravenous infusions over a two-week period. The duration of benefit varies from one individual to another though subsequent treatment sessions may be needed. That is a determination that is jointly made by the patient. and the treating psychiatrist. One needs to keep in mind that there is no guarantee that every individual. who tries this treatment will experience similar benefit as individual results vary. With a close to 70% response rate in the literature, Ketamine is being hailed as an unprecedentedly successful. advance in the treatment of treatment-resistant depression, PTSD and chronic pain.The practice follows the guidelines developed. from the NIHM clinical trial protocol calling for six intravenous infusions over a two-week period. The duration of benefit varies from one individual to another though subsequent treatment sessions may be needed. That is a determination that is jointly made by the patient. and the treating psychiatrist. One needs to keep in mind that there is no guarantee that every individual. who tries this treatment will experience similar benefit as individual results vary. With a close to 70% response rate in the literature, Ketamine is being hailed as an unprecedentedly successful. advance in the treatment of treatment-resistant depression, PTSD and chronic pain.
depression

GROUND BREAKING DEPRESSION TREATMENT

The only Intravenous Ketamine  provider in +400 miles

Safe, Effective, Life-Changing

The practice follows the guidelines developed from the NIHM clinical trial protocol calling for six intravenous infusions over a two-week period. The duration of benefit varies from one individual to another though subsequent treatment sessions may be needed. That is a determination that is jointly made by the patient and the treating psychiatrist. One needs to keep in mind that there is no guarantee that every individual who tries this treatment will experience similar benefit as individual results vary. With a close to 70% response rate in the literature, Ketamine is being hailed as an unprecedentedly successful advance in the treatment of treatment-resistant depression, PTSD and chronic pain.

Depression Treatment
Depression Treatment

A New Hope Against Depression

If you or a loved one is struggling with a long standing history of clinical depression that has not responded to multiple medication trials and psychotherapy, you may want to f nd out if Ketamine infusion may be a life altering treatment. Because this is such a ground-breaking and innovative treatment, insurance companies do not pay for the Ketamine infusion procedures. The practice will request that you pay for these treatments yourself. However, the initial psychiatric consultation may be covered by your existing insurance program.

Many Conditions, One Treatmet

For PTSD, chronic pain, and treatment-resistant depression, regardless of cause, there is now a breakthrough treatment that may be a game changer. This treatment may significantly improve the quality of life for individuals suffering from unipolar or bipolar depression, suicidal issues, PTSD, and chronic pain issues, among others.

Depression Treatment